FDA panel vetoes OTC version of cholesterol drug.
Walczak
I M
IM
D000924:Anticholesteremic Agents / Q000627:therapeutic use; D004348:Drug Labeling; D006801:Humans; D008148:Lovastatin / Q000627:therapeutic use; D004366:Nonprescription Drugs / Q000627:therapeutic use; D017035:Pravastatin / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
D000924:Anticholesteremic Agents; D004366:Nonprescription Drugs; D008148:Lovastatin; D017035:Pravastatin